OEA’s Relationship to Anandamide Did Not Make Its Feeding Effect Cannabinoid-Receptor Activation
Oleylethanolamide is structurally related to anandamide, but the supplied study reported that it does not activate cannabinoid receptors. Its feeding effects in rats therefore should not be described as another demonstration of THC-like receptor action.
Related lipids can have different targets
The study described stimulus-dependent OEA production and rapid enzymatic elimination, properties consistent with a signaling role. Structural relationship and shared handling do not establish identical receptor pharmacology. Calling all such fatty-acid ethanolamides cannabinoids would obscure the specific target question.
The feeding result pointed toward a peripheral contribution
Food deprivation reduced OEA biosynthesis in the small intestine. Administered OEA reduced food intake and body-mass gain, but brain-ventricle administration did not reproduce the feeding effect. Removing peripheral sensory fibers with capsaicin prevented the action. These comparisons supported peripheral regulation rather than a simple direct central injection effect.
Brain activation did not settle the initiating site
The study associated OEA treatment with activation of selected satiety-related brain regions. A downstream brain response can coexist with a peripheral initiating mechanism. The data do not establish every intermediate signal, nor do they validate a human appetite treatment or a clinical comparison with THC.
Interpreting the evidence
This experiment distinguishes a lipid's chemical family from its receptor action and route-dependent physiology. It does not establish that OEA supplements and cannabis are interchangeable interventions.
Related reading: endocannabinoid pathways and the limits of clinical extrapolation.
Research reference
Rodríguez de Fonseca F; Navarro M; Gómez R; et al. (2001). An anorexic lipid mediator regulated by feeding. Nature. doi:10.1038/35102582. Evidence basis: report abstract.
